000 | 01140 a2200313 4500 | ||
---|---|---|---|
005 | 20250513064006.0 | ||
264 | 0 | _c19940610 | |
008 | 199406s 0 0 eng d | ||
022 | _a0886-022X | ||
024 | 7 |
_a10.3109/08860229409044856 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOken, D E | |
245 | 0 | 0 |
_aRenal and extrarenal considerations in high-dose mannitol therapy. _h[electronic resource] |
260 |
_bRenal failure _c1994 |
||
300 |
_a147-59 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 |
_aBrain Edema _xdrug therapy |
650 | 0 | 4 |
_aExtracellular Space _xdrug effects |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyponatremia _xchemically induced |
650 | 0 | 4 |
_aMannitol _xadministration & dosage |
650 | 0 | 4 |
_aWater-Electrolyte Balance _xdrug effects |
773 | 0 |
_tRenal failure _gvol. 16 _gno. 1 _gp. 147-59 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/08860229409044856 _zAvailable from publisher's website |
999 |
_c8183458 _d8183458 |